CORCEPT THERAPEUTICS INC — Director's Dealing 2018

Feb 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2018-02-07

Reporting Person: FISHMAN ROBERT S (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-07	Common Stock	M	8000	$3.51	Acquired	8000	Direct
2018-02-07	Common Stock	S	8000	$16.5968	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-07	Stock Option (Right to Buy)	$3.51	M	8000	Disposed	2025-09-29	Common Stock (8000)	Direct
2018-02-07	Stock Option (Right to Buy)	$16.52	A	150000	Acquired	2028-02-07	Common Stock (150000)	Direct

Footnotes

F1: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.

F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $16.34 to $16.93 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.

F3: Shares subject to this stock option vest and become exercisable at the rate of 25% of the total number at the first anniversary of September 28, 2015. Thereafter, 1/48th of the total number of shares subject to this option grant vests and becomes exercisable on each monthly anniversary, so that the total number of shares subject to this option becomes fully vested and exercisable on September 28, 2019.

F4: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2018, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2022.